Is the Endothelium the Missing Link in the Pathophysiology and Treatment of COVID-19 Complications?
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Is the Endothelium the Missing Link in the Pathophysiology and Treatment of COVID-19 Complications?
Authors
Keywords
-
Journal
CARDIOVASCULAR DRUGS AND THERAPY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-06-07
DOI
10.1007/s10557-021-07207-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients
- (2021) Yu Zuo et al. Scientific Reports
- Demographic risk factors for COVID-19 infection, severity, ICU admission and death: a meta-analysis of 59 studies
- (2021) Bart G Pijls et al. BMJ Open
- COVID-19-Associated Hyper-Fibrinolysis: Mechanism and Implementations
- (2021) Giris Jacob et al. Frontiers in Physiology
- Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
- (2020) Haibo Zhang et al. INTENSIVE CARE MEDICINE
- Abnormal Coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
- (2020) Ning Tang et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia
- (2020) Qun Li et al. NEW ENGLAND JOURNAL OF MEDICINE
- The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19–infected patients
- (2020) Steven P. Treon et al. BLOOD
- COVID-19 and its implications for thrombosis and anticoagulation
- (2020) Jean Marie Connors et al. BLOOD
- COVID19 coagulopathy in Caucasian patients
- (2020) Helen Fogarty et al. BRITISH JOURNAL OF HAEMATOLOGY
- Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
- (2020) Daniel Blanco-Melo et al. CELL
- SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues
- (2020) Carly G.K. Ziegler et al. CELL
- Proteomic and Metabolomic Characterization of COVID-19 Patient Sera
- (2020) Bo Shen et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Heparanase, cell signaling, and viral infections
- (2020) Raghuram Koganti et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study
- (2020) Julie Helms et al. INTENSIVE CARE MEDICINE
- Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial
- (2020) Yang Cao et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Complement activation in patients with COVID-19: A novel therapeutic target
- (2020) Massimo Cugno et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Fibrinolysis Shutdown Correlates to Thromboembolic Events in Severe COVID-19 Infection
- (2020) Franklin L. Wright et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- DOACs and ‘newer’ haemophilia therapies in COVID-19
- (2020) Jecko Thachil et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis‐associated coagulopathy: A systematic review and meta‐analysis
- (2020) Emanuele Valeriani et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Tissue plasminogen activator (tPA) treatment for COVID‐19 associated acute respiratory distress syndrome (ARDS): A case series
- (2020) Janice Wang et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- ISTH interim guidance on recognition and management of coagulopathy in COVID‐19
- (2020) Jecko Thachil et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
- (2020) Ning Tang et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- The procoagulant pattern of patients with COVID‐19 acute respiratory distress syndrome
- (2020) Marco Ranucci et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Lupus anticoagulant is frequent in patients with Covid‐19
- (2020) Inès Harzallah et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Endothelial cell infection and endotheliitis in COVID-19
- (2020) Zsuzsanna Varga et al. LANCET
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
- (2020) Yeming Wang et al. LANCET
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
- (2020) Maximilian Ackermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19
- (2020) Louise Bowles et al. NEW ENGLAND JOURNAL OF MEDICINE
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
- (2020) Yan Zhang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cytokine release syndrome in severe COVID-19
- (2020) John B. Moore et al. SCIENCE
- D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis
- (2020) Giuseppe Lippi et al. THROMBOSIS AND HAEMOSTASIS
- Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases
- (2020) Cynthia Magro et al. Translational Research
- Apixaban Downregulates Endothelial Inflammatory and Prothrombotic Phenotype in an In Vitro Model of Endothelial Dysfunction in Uremia
- (2020) Sergi Torramade-Moix et al. CARDIOVASCULAR DRUGS AND THERAPY
- The first case of COVID-19 treated with the complement C3 inhibitor AMY-101
- (2020) Sara Mastaglio et al. CLINICAL IMMUNOLOGY
- Complement C5 inhibition in patients with COVID-19 - a promising target?
- (2020) Regis Peffault de Latour et al. HAEMATOLOGICA
- Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19
- (2020) Ling Li et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Defibrotide inhibits donor leucocyte‐endothelial interactions and protects against acute graft‐versus‐host disease
- (2020) David García‐Bernal et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past
- (2020) Dimitrios Giannis et al. JOURNAL OF CLINICAL VIROLOGY
- Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study
- (2020) Fabrizio Cantini et al. JOURNAL OF INFECTION
- p38 MAPK inhibition: A promising therapeutic approach for COVID-19
- (2020) Joseph M. Grimes et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Curative anticoagulation prevents endothelial lesion in COVID‐19 patients
- (2020) Lina Khider et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Fibrinolysis and COVID‐19: a tale of two sites?
- (2020) Charithani B. Keragala et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- ISTH DIC Subcommittee Communication on Anticoagulation in COVID‐19
- (2020) Jecko Thachil et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Antiphospholipid antibodies in patients with COVID‐19: A relevant observation?
- (2020) Katrien M. J. Devreese et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Fibrinolysis and COVID‐19: A plasmin paradox
- (2020) Robert L. Medcalf et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Hypofibrinolytic state and high thrombin generation may play a major role in SARS‐COV2 associated thrombosis
- (2020) Christophe Nougier et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Coagulopathy in COVID‐19
- (2020) Toshiaki Iba et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Potential role for tissue factor in the pathogenesis of hypercoagulability associated with in COVID-19
- (2020) Mario Bautista-Vargas et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis
- (2020) F.A. Klok et al. THROMBOSIS RESEARCH
- Endothelial Damage, Inflammation and Immunity in Chronic Kidney Disease
- (2020) Maribel Diaz-Ricart et al. Toxins
- Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study
- (2020) George Goshua et al. Lancet Haematology
- The complement system in COVID-19: friend and foe?
- (2020) Anuja Java et al. JCI Insight
- Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition
- (2020) Jia Yu et al. BLOOD
- SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2
- (2020) Thomas Mandel Clausen et al. CELL
- Characterization of the cytokine storm reflects hyperinflammatory endothelial dysfunction in COVID-19
- (2020) Jonathan T. Sims et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19
- (2020) Girish N. Nadkarni et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Incidence of Deep Vein Thrombosis among non‐ICU Patients Hospitalized for COVID‐19 Despite Pharmacological Thromboprophylaxis:
- (2020) Angelo Porfidia et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
- (2020) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome
- (2020) Sujin Kang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mechanisms of SARS-CoV-2 transmission and pathogenesis
- (2020) Andrew G. Harrison et al. TRENDS IN IMMUNOLOGY
- Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia
- (2020) Olivier Hermine et al. JAMA Internal Medicine
- Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia
- (2020) Carlo Salvarani et al. JAMA Internal Medicine
- Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes
- (2020) Daniel E Leisman et al. Lancet Respiratory Medicine
- Increased Plasma Heparanase Activity in COVID-19 Patients
- (2020) Baranca Buijsers et al. Frontiers in Immunology
- Complement activation and endothelial perturbation parallel COVID-19 severity and activity
- (2020) Massimo Cugno et al. JOURNAL OF AUTOIMMUNITY
- REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19
- (2020) David M. Weinreich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
- (2020) Carlos Salama et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Proteolytic Regulation of Virus Cell Entry by Furin and Other Proprotein Convertases
- (2019) Gonzalo Izaguirre Viruses-Basel
- Complement Activation and Thrombotic Microangiopathies
- (2019) Marta Palomo et al. Clinical Journal of the American Society of Nephrology
- Up‐regulation of HDACs, a harbinger of uraemic endothelial dysfunction, is prevented by defibrotide
- (2019) Marta Palomo et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Acute Graft-vs.-Host Disease-Associated Endothelial Activation in vitro Is Prevented by Defibrotide
- (2019) Julia Martinez-Sanchez et al. Frontiers in Immunology
- Use of Defibrotide to help prevent post-transplant endothelial injury in a genetically predisposed infant with metachromatic leukodystrophy undergoing hematopoietic stem cell gene therapy
- (2018) Valeria Calbi et al. BONE MARROW TRANSPLANTATION
- Cytokine release syndrome
- (2018) Alexander Shimabukuro-Vornhagen et al. Journal for ImmunoTherapy of Cancer
- Mechanisms of Dysfunction in the Aging Vasculature and Role in Age-Related Disease
- (2018) Anthony J. Donato et al. CIRCULATION RESEARCH
- Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis
- (2018) Lisa E. Gralinski et al. mBio
- Risk of developing antiphospholipid antibodies following viral infection: a systematic review and meta-analysis
- (2017) N Abdel-Wahab et al. LUPUS
- Endothelial glycocalyx—the battleground for complications of sepsis and kidney injury
- (2017) Jong Wook Song et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- More than an anticoagulant: Do heparins have direct anti-inflammatory effects?
- (2017) Timothy J. Poterucha et al. THROMBOSIS AND HAEMOSTASIS
- Interleukin 6 Inhibition and Coronary Artery Disease in a High‐Risk Population: A Prospective Community‐Based Clinical Study
- (2017) Bruno Cesar Bacchiega et al. Journal of the American Heart Association
- Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure
- (2016) P. G. Richardson et al. BLOOD
- What is going on between defibrotide and endothelial cells? Snapshots reveal the hot spots of their romance
- (2016) M. Palomo et al. BLOOD
- The Endothelium in Sepsis
- (2016) Can Ince et al. SHOCK
- p38 MAPK inhibitors: a patent review (2012 – 2013)
- (2014) Stefanie Bühler et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Loss of the Endothelial Glucocorticoid Receptor Prevents the Therapeutic Protection Afforded by Dexamethasone after LPS
- (2014) Julie E. Goodwin et al. PLoS One
- Activated protein C attenuates pulmonary coagulopathy in patients with acute respiratory distress syndrome
- (2013) A. D. Cornet et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Plasminogen Controls Inflammation and Pathogenesis of Influenza Virus Infections via Fibrinolysis
- (2013) Fatma Berri et al. PLoS Pathogens
- Cardiovascular Risk Factors and Systemic Endothelial Function in Patients With Cirrhosis
- (2012) Annalisa Berzigotti et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial
- (2012) Selim Corbacioglu et al. LANCET
- NFκB in the Development of Endothelial Activation and Damage in Uremia: An In Vitro Approach
- (2012) Carolina Caballo et al. PLoS One
- The role of the endothelium in the short-term complications of hematopoietic SCT
- (2011) E Carreras et al. BONE MARROW TRANSPLANTATION
- Complement-mediated injury and protection of endothelium: Lessons from atypical haemolytic uraemic syndrome
- (2011) Heather Kerr et al. IMMUNOBIOLOGY
- A Systems Biology Approach for the Investigation of the Heparin/Heparan Sulfate Interactome
- (2011) Alessandro Ori et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Translational evidence of endothelial damage in obese individuals: inflammatory and prothrombotic responses
- (2011) F. A. HANZU et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease and Multiorgan Failure after Stem Cell Transplantation: A Multicenter, Randomized, Dose-Finding Trial
- (2010) Paul G. Richardson et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- The Release of Soluble Factors Contributing to Endothelial Activation and Damage after Hematopoietic Stem Cell Transplantation Is Not Limited to the Allogeneic Setting and Involves Several Pathogenic Mechanisms
- (2009) Marta Palomo et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Preclinical Studies in Support of Defibrotide for the Treatment of Multiple Myeloma and Other Neoplasias
- (2009) C. S. Mitsiades et al. CLINICAL CANCER RESEARCH
- Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
- (2009) T. H. Mogensen CLINICAL MICROBIOLOGY REVIEWS
- Atypical Hemolytic–Uremic Syndrome
- (2009) Marina Noris et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation